Panacea Biotec Limited (NSE:PANACEABIO)

India · Delayed Price · Currency is INR

411.90

+10.50 (2.62%)

Aug 4, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2016 - 2018
Vaccines	3.60B	Log In	Log In	Log In	Log In	Upgrade
Vaccines Growth	39.93%	Log In	Log In	Log In	Log In	Upgrade
Formulations	2.00B	Log In	Log In	Log In	Log In	Upgrade
Formulations Growth	-1.67%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2016 - 2018
Overseas	4.81B	Log In	Log In	Log In	Log In	Upgrade
Overseas Growth	37.94%	Log In	Log In	Log In	Log In	Upgrade
India	777.68M	Log In	Log In	Log In	Log In	Upgrade
India Growth	-29.90%	Log In	Log In	Log In	Log In	Upgrade